Physician

Suzan Egeli House, MD

According to 2025 Medicare claims, Suzan House, MD (NPI: 1831132984) practices rheumatology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Hamilton, TN. This provider's primary affiliated billing organization is SCENIC CITY RHEUMATOLOGY, PLLC (NPI: 1871647800; TIN: 20-2779548) and primary practice location at 37421-7808. House is affiliated with the Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

House's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 666 traditional Medicare patients, billed 146,655 HCPCS/CPT codes, and received $1,611,715 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,420 prescription claims across 354 beneficiaries totaling $1,151,923 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2016 DME data shows 12 claims. Open Payments data shows 102 records totaling $2,419. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	461	58,521	$1,048,229
2016	446	80,334	$1,355,533
2017	440	105,914	$1,694,405
2018	414	117,084	$1,824,386
2019	427	117,127	$1,859,215
2020	317	98,579	$1,429,883
2021	346	96,007	$1,435,143
2022	425	116,760	$1,389,406
2023	571	138,145	$1,402,957
2024	666	146,655	$1,611,715

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	462	4,903	$1,059,724
2016	393	4,807	$1,234,391
2017	366	4,315	$1,054,932
2018	362	3,754	$999,606
2019	357	3,490	$1,048,375
2020	317	2,985	$958,902
2021	315	3,287	$1,130,969
2022	314	3,109	$1,148,058
2023	330	2,636	$883,872
2024	354	2,420	$1,151,923

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$448
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	122	153	$131
96413	Administration of chemotherapy into vein, 1 hour or less	113	393	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	570	1,032	$91
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	331	509	$13
J1010	Injection, methylprednisolone acetate, 1 mg	113	9,880	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	27	756	$262,557
Xeljanz Xr	Tofacitinib Citrate	24	720	$143,162
Enbrel Sureclick	Etanercept	17	476	$125,503
Rinvoq	Upadacitinib	15	450	$95,275
Otezla	Apremilast	17	510	$79,150

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	102	$2,419	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Suzan Egeli House, MD?

Tedicare shows public-source Medicare data for Suzan Egeli House, MD (NPI 1831132984), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Suzan Egeli House, MD have ACO affiliation data?

Suzan Egeli House, MD is shown with ACO affiliation data for Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Suzan Egeli House, MD?

Suzan Egeli House, MD is linked to SCENIC CITY RHEUMATOLOGY, PLLC (billing NPI 1871647800) in the available physician profile data.

Does Suzan Egeli House, MD have Open Payments data?

Suzan Egeli House, MD has 102 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.